Overview

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)

Status:
Not yet recruiting

Trial end date:
2025-12-03

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety and tolerability of Ruxolitinib cream in participants with Prurigo Nodularis (PN).

Phase:

Phase 3

Details

Lead Sponsor:

Incyte Corporation